Потеря слуха у детей с очень низкой массой тела при рождении: современный обзор эпидемиологии и патофизиологии
REFERENCES
1. Ehrenhaft PM, Wagner JL, Herdman RC. Changing prognosis for very low birth weight infants. Obstet Gynecol. 1989;74:528–535. [PubMed] [Google Scholar]
2. Oghalai JS. The cochlear amplifier: augmentation of the traveling wave within the inner ear. Curr Opin Otolaryngol Head Neck Surg. 2004;12:431–438. [PMC free article] [PubMed] [Google Scholar]
3. Balkany TJ, Downs MP, Jafek BW, et al. Otologic manifestations of Down’s syndrome. Surg Forum. 1978;29:582–585. [PubMed] [Google Scholar]
4. Doyle KJ, Kong YY, Strobel K, et al. Neonatal middle ear effusion predicts chronic otitis media with effusion. Otol Neurotol. 2004;25:318–322. [PubMed] [Google Scholar]
5. van Straaten HL, Tibosch CH, Dorrepaal C, et al. Efficacy of automated auditory brainstem response hearing screening in very preterm newborns. J Pediatr. 2001;138:674–678. [PubMed] [Google Scholar]
6. van Straaten HL, Hille ET, Kok JH, et al. Implementation of a nation-wide automated auditory brainstem response hearing screening programme in neonatal intensive care units. Acta Paediatr. 2003;92:332–338. [PubMed] [Google Scholar]
7. Berg AL, Spitzer JB, Towers HM, et al. Newborn hearing screening in the NICU: profile of failed auditory brainstem response/passed otoacoustic emission. Pediatrics. 2005;116:933–938. [Erratum in Pediatrics 2006;117:997.] [PubMed] [Google Scholar]
8. Hearing JCoI. Year 2007 position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics. 2007;120:989–1021. [PubMed] [Google Scholar]
9. Cone-Wesson B, Vohr BR, Sininger YS, et al. Identification of neonatal hearing impairment: infants with hearing loss. Ear Hear. 2000;21:488–507. [PubMed] [Google Scholar]
10. Parving A. Detection of the infant with congenital/early acquired hearing disability. Acta Otolaryngol Suppl. 1991;482:111–116. [discussion 7] [PubMed] [Google Scholar]
11. Davis A, Wood S. The epidemiology of childhood hearing impairment: factor relevant to planning of services. Br J Audiol. 1992;26:77–90. [PubMed] [Google Scholar]
12. Mehl AL, Thomson V. The Colorado newborn hearing screening project: 1992–1999: on the threshold of effective population-based universal newborn hearing screening. Pediatrics. 2002;109:E7. [See comment.] [PubMed] [Google Scholar]
13. Russ SA, Rickards F, Poulakis Z, et al. Six year effectiveness of a population based two tier infant hearing screening programme. Arch Dis Child. 2002;86:245–250. [PMC free article] [PubMed] [Google Scholar]
14. Prieve B, Dalzell L, Berg A, et al. The New York State universal newborn hearing screening demonstration project: outpatient outcome measures. Ear Hear. 2000;21:104–117. [See comment.] [PubMed] [Google Scholar]
15. Watkin PM, Baldwin M. Confirmation of deafness in infancy. Arch Dis Child. 1999;81:380–389. [PMC free article] [PubMed] [Google Scholar]
16. Wessex Universal Neonatal Hearing Screening Trial Group. Controlled trial of universal neonatal screening for early identification of permanent childhood hearing impairment. Lancet. 1998;352:1957–1964. [PubMed] [Google Scholar]
17. Maki-Torkko EM, Lindholm PK, Vayrynen MR, et al. Epidemiology of moderate to profound childhood hearing impairments in northern Finland. Any changes in ten years? Scand Audiol. 1998;27:95–103. [PubMed] [Google Scholar]
18. Van Naarden K, Decoufle P, Caldwell K. Prevalence and characteristics of children with serious hearing impairment in metropolitan Atlanta: 1991–1993. Pediatrics. 1999;103:570–575. [See comment.] [PubMed] [Google Scholar]
19. Smyth V, Scott J, Tudehope D. Auditory brainstem evoked response inter-peak latencies in very low birthweight infants. Int J Pediatr Otorhinolaryngol. 1988;16:69–76. [PubMed] [Google Scholar]
20. Veen S, Sassen ML, Schreuder AM, et al. Hearing loss in very preterm and very low birthweight infants at the age of 5 years in a nationwide cohort. Int J Pediatr Otorhinolaryngol. 1993;26:11–28. [PubMed] [Google Scholar]
21. Meyer C, Witte J, Hildmann A, et al. Neonatal screening for hearing disorders in infants at risk: incidence, risk factors, and follow-up. Pediatrics. 1999;104:900–904. [PubMed] [Google Scholar]
22. Perrott S, Dodds L, Vincer M. A population-based study of prognostic factors related to major disability in very preterm survivors. J Perinatol. 2003;23:111–116. [PubMed] [Google Scholar]
23. Oghalai JS, Chen L, Brennan ML, et al. Neonatal hearing loss in the indigent. The Laryngoscope. 2002;112:281–286. [PubMed] [Google Scholar]
24. Abramovich SJ, Gregory S, Slemick M, et al. Hearing loss in very low birthweight infants treated with neonatal intensive care. Arch Dis Child. 1979;54:421–426. [PMC free article] [PubMed] [Google Scholar]
25. Bergman I, Hirsch RP, Fria TJ, et al. Cause of hearing loss in the high-risk premature infant. J Pediatr. 1985;106:95–101. [PubMed] [Google Scholar]
26. Bradford BC, Baudin J, Conway MJ, et al. Identification of sensory neural hearing loss in very preterm infants by brainstem auditory evoked potentials. Arch Dis Child. 1985;60:105–109. [PMC free article] [PubMed] [Google Scholar]
27. Salamy A, Eldredge L, Tooley WH. Neonatal status and hearing loss in high-risk infants. J Pediatr. 1989;114:847–852. [PubMed] [Google Scholar]
28. Jiang ZD, Brosi DM, Wilkinson AR. Hearing impairment in preterm very low birthweight babies detected at term by brainstem auditory evoked responses. Acta Paediatr. 2001;90:1411–1415. [PubMed] [Google Scholar]
29. Korres S, Nikolopoulos TP, Komkotou V, et al. Newborn hearing screening: effectiveness, importance of high-risk factors, and characteristics of infants in the neonatal intensive care unit and well-baby nursery. Otol Neurotol. 2005;26:1186–1190. [PubMed] [Google Scholar]
30. Rosenfeld RM, Bluestone CD. Evidence-based otitis media. 2nd edn. Hamilton, Ont, Lewiston, NY: BC Decker; 2003. [Google Scholar]
31. Ari-Even Roth D, Hildesheimer M, Maayan-Metzger A, et al. Low prevalence of hearing impairment among very low birthweight infants as detected by universal neonatal hearing screening. Arch Dis Child Fetal Neonatal Ed. 2006;91:F257–F262. [PMC free article] [PubMed] [Google Scholar]
32. Epstein S, Reilly JS. Sensorineural hearing loss. Pediatr Clin North Am. 1989;36:1501–1520. [PubMed] [Google Scholar]
33. Joint Committee on Infant Hearing, American Academy of Audiology, American Academy of Pediatrics, American Speech-Language-Hearing Association, and Directors of Speech and Hearing Programs in State Health and Welfare Agencies. Year 2000 position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics. 2000;106:798–817. [PubMed] [Google Scholar]
34. Norton SJ, Gorga MP, Widen JE, et al. Identification of neonatal hearing impairment: summary and recommendations. Ear Hear. 2000;21:529–535. [PubMed] [Google Scholar]
35. Vohr BR, Widen JE, Cone-Wesson B, et al. Identification of neonatal hearing impairment: characteristics of infants in the neonatal intensive care unit and wellbaby nursery. Ear Hear. 2000;21:373–382. [PubMed] [Google Scholar]
36. Oghalai JS. Cochlear hearing loss. In: Jackler RK, Brackmann DE, editors. Neurotology. 2nd edn. Philadelphia: Mosby; 2005. pp. 589–606. [Google Scholar]
37. Steel KP, Kros CJ. A genetic approach to understanding auditory function. Nat Genet. 2001;27:143–149. [PubMed] [Google Scholar]
38. Young TE, Magnum OB. Neofax: a manual of drugs used in neonatal care. 20th edn. Thomson Healthcare; 2007. [Google Scholar]
39. Marlow ES, Hunt LP, Marlow N. Sensorineural hearing loss and prematurity. Arch Dis Child Fetal Neonatal Ed. 2000;82:F141–F144. [PMC free article] [PubMed] [Google Scholar]
40. Fanaroff JM, Wilson-Costello DE, Newman NS, et al. Treated hypotension is associated with neonatal morbidity and hearing loss in extremely low birth weight infants. Pediatrics. 2006;117:1131–1135. [PubMed] [Google Scholar]
41. Forge A, Schacht J. Aminoglycoside antibiotics. Audiol Neurootol. 2000;5:3–22. [PubMed] [Google Scholar]
42. Rotstein C, Mandell L. Clinical aminoglycoside ototoxicity. In: Roland PS, Rutka JA, editors. Ototoxicity. Hamilton, Ont: BC Decker; 2004. pp. 82–92. [Google Scholar]
43. Fausti SA, Henry JA, Helt WJ, et al. An individualized, sensitive frequency range for early detection of ototoxicity. Ear Hear. 1999;20:497–505. [PubMed] [Google Scholar]
44. Kawamoto K, Sha SH, Minoda R, et al. Antioxidant gene therapy can protect hearing and hair cells from ototoxicity. Mol Ther. 2004;9:173–181. [PubMed] [Google Scholar]
45. Becvarovski Z, Michaelides EM, Kartush JM, et al. Rapid elevation of gentamicin levels in the human labyrinth following intravenous administration. Laryngoscope. 2002;112:1163–1165. [PubMed] [Google Scholar]
46. Rizzi MD, Hirose K. Aminoglycoside ototoxicity. Curr Opin Otolaryngol Head Neck Surg. 2007;15:352–357. [PubMed] [Google Scholar]
47. Casano RA, Johnson DF, Bykhovskaya Y, et al. Inherited susceptibility to aminoglycoside ototoxicity: genetic heterogeneity and clinical implications. Am J Otolaryngol. 1999;20:151–156. [PubMed] [Google Scholar]
48. Guan MX. Molecular pathogenetic mechanism of maternally inherited deafness. Ann N Y Acad Sci. 2004;1011:259–271. [PubMed] [Google Scholar]
49. Stavroulaki P, Apostolopoulos N, Dinopoulou D, et al. Otoacoustic emissions: an approach for monitoring aminoglycoside induced ototoxicity in children. Int J Pediatr Otorhinolaryngol. 1999;50:177–184. [PubMed] [Google Scholar]
50. Fausti SA, Larson VD, Noffsinger D, et al. High-frequency audiometric monitoring strategies for early detection of ototoxicity. Ear Hear. 1994;15:232–239. [PubMed] [Google Scholar]
51. American Speech-Language-Hearing Association. Audiologic managment of individuals receiving cochleotoxic drug therapy. Guidelines for the audiologic management of individuals receiving cochleotoxic drug therapy. ASHA Supplement. 1994;36(Suppl 12):11–19. [Google Scholar]
52. Bajaj M, Palmer K. Gentamicin usage in newborns: an audit. Arch Dis Child. 2003;88:645. [comment] [PMC free article] [PubMed] [Google Scholar]
53. Rao SC, Ahmed M, Hagan R. One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev. 2006;(1):CD005091. [PubMed] [Google Scholar]
54. Nestaas E, Bangstad HJ, Sandvik L, et al. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2005;90:F294–F300. [See comment.] [PMC free article] [PubMed] [Google Scholar]
55. Best EJ, Palasanthiran P, Gazarian M. Extended-interval aminoglycosides in children: more guidance is needed. Pediatrics. 2005;115:827–828. author reply 8 [comment] [PubMed] [Google Scholar]
56. Loughnan PM. Single daily dose aminoglycosides in the neonatal period appear to be effective: but are they safe? Arch Dis Child Fetal Neonatal Ed. 2006;91:F156. [comment] [PMC free article] [PubMed] [Google Scholar]
57. Humes HD. Insights into ototoxicity. Analogies to nephrotoxicity. Ann N Y Acad Sci. 1999;884:15–18. [PubMed] [Google Scholar]
58. Ding D, McFadden SL, Browne RW, et al. Late dosing with ethacrynic acid can reduce gentamicin concentration in perilymph and protect cochlear hair cells. Hearing Res. 2003;185:90–96. [PubMed] [Google Scholar]
59. Brown DR, Watchko JF, Sabo D. Neonatal sensorineural hearing loss associated with furosemide: a case-control study. Dev Med Child Neurol. 1991;33:816–823. [PubMed] [Google Scholar]
60. Robertson CM, Tyebkhan JM, Peliowski A, et al. Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. Acta Paediatr. 2006;95:214–223. [PubMed] [Google Scholar]
61. Williams AL, van Drongelen W, Lasky RE. Noise in contemporary neonatal intensive care. J Acoust Soc Am. 2007;121:2681–2690. [PubMed] [Google Scholar]
62. Le Prell CG, Yamashita D, Minami SB, et al. Mechanisms of noise-induced hearing loss indicate multiple methods of prevention. Hear Res. 2007;226:22–43. [PMC free article] [PubMed] [Google Scholar]
63. Kramer S, Dreisbach L, Lockwood J, et al. Efficacy of the antioxidant Nacetylcysteine (NAC) in protecting ears exposed to loud music. J Am Acad Audiol. 2006;17:265–278. [PubMed] [Google Scholar]
64. Shapiro SM, Nakamura H. Bilirubin and the auditory system. J Perinatol. 2001;21(Suppl 1):S52–S55. discussion S9-62. [PubMed] [Google Scholar]
65. De Vries LS, Lary S, Whitelaw AG, et al. Relationship of serum bilirubin levels and hearing impairment in newborn infants. Early Hum Dev. 1987;15:269–277. [PubMed] [Google Scholar]
66. Wong V, Chen WX, Wong KY. Short- and long-term outcome of severe neonatal nonhemolytic hyperbilirubinemia. J Child Neurol. 2006;21:309–315. [PubMed] [Google Scholar]
67. Schleiss MR. Nonprimate models of congenital cytomegalovirus (CMV) infection: gaining insight into pathogenesis and prevention of disease in newborns. ILAR J. 2006;47:65–72. [PubMed] [Google Scholar]
68. Katano H, Sato Y, Tsutsui Y, et al. Pathogenesis of cytomegalovirus-associated labyrinthitis in a guinea pig model. Microbes Infect. 2007;9:183–191. [PubMed] [Google Scholar]
69. Rarey KE, Davis LE. Temporal bone histopathology 14 years after cytomegalic inclusion disease: a case study. Laryngoscope. 1993;103:904–909. [PubMed] [Google Scholar]
70. Haupt H, Scheibe F, Ludwig C. Changes in cochlear oxygenation, microcirculation and auditory function during prolonged general hypoxia. Eur Arch Otorhinolaryngol. 1993;250:396–400. [PubMed] [Google Scholar]
71. Sohmer H, Freeman S, Malachi S. Multi-modality evoked potentials in hypoxaemia. Electroencephalogr Clin Neurophysiol. 1986;64:328–333. [PubMed] [Google Scholar]
72. Koyama S, Kaga K, Sakata H, et al. Pathological findings in the temporal bone of newborn infants with neonatal asphyxia. Acta Otolaryngol. 2005;125:1028–1032. [PubMed] [Google Scholar]
73. Rais-Bahrami K, Majd M, Veszelovszky E, et al. Use of furosemide and hearing loss in neonatal intensive care survivors. Am J Perinatol. 2004;21:329–332. [PubMed] [Google Scholar]
74. National Institutes of Health Consensus Development Conference Statement. Early identification of hearing impairment in infants and young children. Int J Pediatr Otorhinolaryngol. 1993;27:215–227. [PubMed] [Google Scholar]
75. Robertson CM, Tyebkhan JM, Hagler ME, et al. Late-onset, progressive sensorineural hearing loss after severe neonatal respiratory failure. Otol Neurotol. 2002;23:353–356. [PubMed] [Google Scholar]
76. Robertson CM, Tyebkhan JM, Peliowski A, et al. Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. Acta Paediatr. 2006;95:214–223. [PubMed] [Google Scholar]
77. Lasky RE, Wiorek L, Becker TR. Hearing loss in survivors of neonatal extracorporeal membrane oxygenation (ECMO) therapy and high-frequency oscillatory (HFO) therapy. J Am Acad Audiol. 1998;9:47–58. [PubMed] [Google Scholar]
78. Fligor BJ, Neault MW, Mullen CH, et al. Factors associated with sensorineural hearing loss among survivors of extracorporeal membrane oxygenation therapy. Pediatrics. 2005;115:1519–1528. [PubMed] [Google Scholar]
79. Karchmer MA, Allen TE. The functional assessment of deaf and hard of hearing students. Am Ann Deaf. 1999;144:68–77. [PubMed] [Google Scholar]
80. Pierson SK, Caudle SE, Krull KR, et al. Cognition in children with sensorineural hearing loss: etiologic considerations. Laryngoscope. 2007;117:1661–1665. [PMC free article] [PubMed] [Google Scholar]
81. Kushalnagar P, Krull K, Hannay J, et al. Intelligence, parental depression, and behavior adaptability in deaf children being considered for cochlear implantation. J Deaf Stud Deaf Educ. 2007;12:335–349. [PubMed] [Google Scholar]
82. Fortnum HM, Summerfield AQ, Marshall DH, et al. Prevalence of permanent childhood hearing impairment in the United Kingdom and implications for universal neonatal hearing screening: questionnaire based ascertainment study. BMJ. 2001;323:536–540. [PMC free article] [PubMed] [Google Scholar]
83. Davis NM, Doyle LW, Ford GW, et al. Auditory function at 14 years of age of verylow- birthweight. Dev Med Child Neurol. 2001;43:191–196. [PubMed] [Google Scholar]
84. Doyle LW, Keir E, Kitchen WH, et al. Audiologic assessment of extremely low birth weight infants: a preliminary report. Pediatrics. 1992;90:744–749. [PubMed] [Google Scholar]